Impact of donor and recipient age on allograft tolerance

Experimental and Clinical Transplantation

Volumn 7, Issue 2, 2009, Pages 67-77

  Martins, Paulo N ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Aging; Immunosenescence; Tolerance induction; Transplant

Indexed keywords

ALPHA4 INTEGRIN; B7 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; CD8 ANTIGEN; CYCLOSPORIN; HEAT SHOCK PROTEIN; HEME OXYGENASE 1; IMMUNOSUPPRESSIVE AGENT; INTERCELLULAR ADHESION MOLECULE 3; INTERLEUKIN 2 RECEPTOR ALPHA; L SELECTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ADAPTIVE IMMUNITY; AGE; AGING; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTERIOSCLEROSIS; CD4+ CD25+ T LYMPHOCYTE; CHRONIC GRAFT REJECTION; COMORBIDITY; DENDRITIC CELL; DIABETES MELLITUS; DONOR SELECTION; ELDERLY CARE; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPERTENSION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; NONHUMAN; ORGAN DONOR; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; REGULATORY T LYMPHOCYTE; REVIEW; STEATOSIS; ANIMAL; ANIMAL MODEL; ARTICLE; DONOR; IMMUNE SYSTEM; IMMUNOLOGY; PHYSIOLOGY; TRANSPLANTATION;

AGING; ANIMALS; GRAFT REJECTION; HUMANS; IMMUNE SYSTEM; IMMUNE TOLERANCE; MODELS, ANIMAL; ORGAN TRANSPLANTATION; TISSUE DONORS; TRANSPLANTATION;

EID: 70350503406     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (175)

1. National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases. US Renal Data System: 1999 Annual Data Report. Bethesda, MD: National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; 1999. This can only be found in the home page
2. Martins PN, Pratschke J, Pascher A, et al. Age and immune response in organ transplantation. Transplantation. 2005;79(2):127-132.
3. Gjertson DW. A multi-factor analysis of kidney graft outcomes at one and five years posttransplantation: 1996 UNOS Update. Clin Transpl. 1996:343-360.
4. Helsop BF, Carter JM, Hornibrook J. Graft immunogenicity as a function of donor age in the rat. Transplant Proc. 1973;5(1):149-152.
5. Reutzel-Selke A, Jurisch A, Denecke C, et al. Donor age intensifies the early immune response after transplantation. Kidney Int. 2007;71(7):629-636. (Pubitemid 46494556)
6. Meier-Kriesche HU, Ojo AO, Cibrik DM, et al. Relationship of recipient age and development of chronic allograft failure. Transplantation. 2000;70(2):306-310.
7. Danovitch GM, Gill J, Bunnapradist S. Immunosuppression of the elderly kidney transplant recipient. Transplantation. 2007;84(3):285-291. (Pubitemid 47258313)
8. Land WG. Ageing and immunosuppression in kidney transplantation. Exp Clin Transplant. 2004;2(2):229-237.
9. Aliabadi AZ, Zuckermann AO, Grimm M. Immunosuppressive therapy in older cardiac transplant patients. Drugs Aging. 2007;24(11):913-932. (Pubitemid 350085753)
10. Meier-Kriesche HU, Ojo A, Hanson J, et al. Increased immunosuppressive vulnerability in elderly renal transplant recipients. Transplantation. 2000;69(5):885-889. (Pubitemid 30174116)
11. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature. 1953;172(4379):603-606.
12. Burnet FM. The Clonal Selection Theory of Acquired Immunity. Nashville, TN: Vanderbilt University Press; 1959.
13. Vetro SW, Bellanti JA. Fetal and neonatal immunoincompetence. Fetal Ther. 1989;4(suppl 1):82-91.
14. Streilein JW. Neonatal tolerance: towards an immunogenetic definition of self. Immunol Rev. 1979;46:123-146.
15. White DJ, Gilks W. The ontogeny of immune responses. J Heart Lung Transplant. 1993;12(6 Pt 2):S301-S308.
16. Ridge JP, Fuchs EJ, Matzinger P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science. 1996;271(5256):1723-1726. (Pubitemid 26102819)
17. Ruiz P, Nassiri M, Gregorian S, Viciana AL, Streilein JW. Neonatal transplantation tolerance is associated with a systemic reduction in memory cells, altered chimeric cell phenotype, and modified eicosanoid and cytokine production. Transplantation. 1996;61(8):1198-1205. (Pubitemid 26134770)
18. Salama AD, Remuzzi G, Harmon WE, Sayegh MH. Challenges to achieving clinical transplantation tolerance. J Clin Invest. 2001;108(7):943-948. (Pubitemid 32946066)
19. do Canto FB, Lima Junior C, Teixeira IA, Bellio M, Nóbrega A, Fucs R. Susceptibility of neonatal T cells and adult thymocytes to peripheral tolerance to allogeneic stimuli. Immunology. 2008;125(3):387-396.
20. Hsu HC, Scott DK, Mountz JD. Impaired apoptosis and immune senescence - cause or effect? Immunol Rev. 2005;205:130-146.
21. Prelog M. Aging of the immune system: a risk factor for autoimmunity? Autoimmun Rev. 2006;5(2):136-139.
22. Urbán L, Bessenyei B, Márka M, Semsei I. On the role of aging in the etiology of autoimmunity. Gerontology. 2002;48(3):179-184.
23. DeKruyff RH, Rinnooy Kan EA, Weksler ME, Siskind GW. Effect of aging on T-cell tolerance induction. Cell Immunol. 1980;56(1):58-67. (Pubitemid 11243002)
24. Habicht GS, Jerrard DA. In "immunological aspect of aging". Dekker. New York, 1981 p. 127.
25. Cowing C, Garabedian C, Leskowitz S. Strain differences in tolerance induction to human gamma-globulin subclasses: dependence on macrophages. Cell Immunol. 1979;47(2):407-415. (Pubitemid 10226578)
26. Ponnappan U, Cinader B, Gerber V, Blaser K. Antibody response and acquired tolerance of A/J mice: age- and immunogen-related isotype differences. Scand J Immunol. 1988;27(4):419-425. (Pubitemid 18107509)
27. Ponnappan U, Gerber V, Blaser K, Cinader B. Isotype-specific resistance against tolerance induction in SJL mice. Cell Immunol. 1986;101(1):242-250. (Pubitemid 16045202)
28. Ponnappan U, Kohno A, Gerber V, Blaser K, Cinader B. Immune response, tolerance circumvention and autoantibodies in aging MRL/Mp-lpr and MRL/Mp-+ mice. Mol Immunol. 1985;22(12):1407-1414. (Pubitemid 16175684)
29. Ponnappan U, Cinader B, Gerber V, Blaser K. Age-dependent changes in isotype expression and down-regulation of C57BL/6 mice. Scand J Immunol. 1987;25(1):45-54. (Pubitemid 17144583)
30. Staples PJ, Talal N. Relative inability to induce tolerance in adult NZB and NZB-NZW F1 mice. J Exp Med. 1969;129(1):123-139.
31. Amagai T, Nakano K, Cinader B. Mechanisms involved in age-dependent decline of immune responsiveness and apparent resistance against tolerance induction in C57BL/6 mice. Scand J Immunol. 1982;16(3):217-231. (Pubitemid 12054672)
32. Hosono M, Cinader B. Resistance to tolerance induction and age-dependent cellular changes in SJL mice. Int Arch Allergy Appl Immunol. 1977;54(4):289-299. (Pubitemid 8137848)
33. Hosono M, Fujiwara M. Studies on the resistance to tolerance induction against human IgG in DDD mice. III. Development of the resistance with age and cellular events. Cell Immunol. 1979;44(2):262-269.
34. Lahmann WM, Menezes JS, Verdolin BA, Vaz NM. Influence of age on the induction of oral tolerance in mice and its adoptive transfer by spleen cells. Braz J Med Biol Res. 1992;25(8):813-821.
35. de Faria AM, Ficker SM, Speziali E, et al. Aging affects oral tolerance induction but not its maintenance in mice. Mech Ageing Dev. 1998;102(1):67-80. (Pubitemid 28256910)
36. Wakabayashi A, Utsuyama M, Hosoda T, Sato K, Hirokawa K. Differential age effect of oral administration of an antigen on antibody response: an induction of tolerance in young mice but enhancement of immune response in old mice. Mech Ageing Dev. 1999;109(3):191-201. (Pubitemid 29421739)
37. Fujiwara M, Cinader B. Cellular aspects of tolerance. VI. The effect of age on responsiveness and tolerance induceability of SJL mice. Cell Immunol. 1974;12(2):205-213.
38. Kato H, Fujihashi K, Kato R, et al. Lack of oral tolerance in aging is due to sequential loss of Peyer's patch cell interactions. Int Immunol. 2003;15(2):145-158. (Pubitemid 36267106)
39. Staples PJ, Steinberg AD, Talal N. Induction of immunologic tolerance in older New Zealand mice repopulated with young spleen, bone marrow, or thymus. J Exp Med. 1970;131(6):1223-1238.
40. Vaz N, Faria AM, Verdolin BA, Carvalho CR. Immaturity, ageing and oral tolerance. Scand J Immunol. 1997;46(3):225-229.
41. Gahring LC, Weigle WO. The effect of aging on the induction of humoral and cellular immunity and tolerance in two long-lived mouse strains. Cell Immunol. 1990;128(1):142-151.
42. Qian T, Ricordi C, Inverardi L, Alejandro R. Intrathymic tolerance and age. Transplant Proc. 1995;27(6):3391.
43. Martins PN, Reutzel-Selke A, Jurisch A, Tullius SG. Donor and recipient age prevent tolerance induction. World Transplantation Congress (WTC). American Journal of Transplantation" 2006;6(Suppl 1); 895.
44. Huang X, Sonawane S, Kim J, et al. Age-dependent transplantation tolerance. Am J Transplant. 2006;6(suppl 1):890. Abstract 2513.
45. Yamada K, Gianello PR, Ierino FL, et al. Role of the thymus in transplantation tolerance in miniature swine: II. Effect of steroids and age on the induction of tolerance to class I mismatched renal allografts. Transplantation. 1999;67(3):458-467.
46. Honma Y, Tani M, Takayama M, Yamamura K, Hasegawa H. Aging abolishes the cardioprotective effect of combination heat shock and hypoxic preconditioning in reperfused rat hearts. Basic Res Cardiol. 2002;97(6):489-495. (Pubitemid 35373477)
47. He Z, Crook JE, Meschia JF, Brott TG, Dickson DW, McKinney M. Aging blunts ischemic-preconditioning-induced neuroprotection following transient global ischemia in rats. Curr Neurovasc Res. 2005;2(5):365-374. (Pubitemid 41789603)
48. Bartling B, Friedrich I, Silber RE, Simm A. Ischemic preconditioning is not cardioprotective in senescent human myocardium. Ann Thorac Surg. 2003;76(1):105-111. (Pubitemid 36819725)
49. Honma Y, Tani M, Yamamura K, Takayama M, Hasegawa H. Preconditioning with heat shock further improved functional recovery in young adult but not in middle-aged rat hearts. Exp Gerontol. 2003;38(3):299-306. (Pubitemid 36170325)
50. Tani M, Suganuma Y, Hasegawa H, et al. Decrease in ischemic tolerance with aging in isolated perfused Fischer 344 rat hearts: relation to increases in intracellular Na+ after ischemia. J Mol Cell Cardiol. 1997;29(11):3081-3089. (Pubitemid 27510774)
51. Nakano K, Cinader B. Accelerated age-dependent decline in the T suppressor capacity of SJL mice. Eur J Immunol. 1980;10(4):309-316. (Pubitemid 10102991)
52. Habicht GS. Acquired immunological tolerance in aged mice. I. The dose-response relationship. Mech Ageing Dev. 1982;19(1):53-62.
53. Francuski M, Reutzel-Selke A, Weiss S, et al. Donor brain death significantly interferes with tolerance induction protocols. Transpl Int. 2009;22(4):482-493.
54. Globerson A, Effros RB. Ageing of lymphocytes and lymphocytes in the aged. Immunol Today. 2000;21(10):515-521.
55. Ginaldi L, DeMartinis M, D'Ostilio A, Marini L, Loreto MF, Quaglino D. Immunological changes in the elderly. Aging (Milano). 1999;11(5):281-286.
56. Wood KJ. New concepts in tolerance. Clin Transplant. 1996;10(1 Pt 2):93-99.
57. Cossarizza A, Ortolani C, Paganelli R, et al. CD45 isoforms expression on CD4+ and CD8+ T cells throughout life, from newborns to centenarians: implications for T cell memory. Mech Ageing Dev. 1996;86(3):173-195. (Pubitemid 26134554)
58. Cossarizza A, Ortolani C, Monti D, Franceschi C. Cytometric analysis of immunosenescence. Cytometry. 1997;27(4):297-313.
59. Lakkis FG, Sayegh MH. Memory T cells: a hurdle to immunologic tolerance. J Am Soc Nephrol. 2003;14(9):2402-2410.
60. Croft M, Bradley LM, Swain SL. Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J Immunol. 1994;152(6):2675-2685. (Pubitemid 24097962)
61. Dengler TJ, Pober JS. Human vascular endothelial cells stimulate memory but not naive CD8+ T cells to differentiate into CTL retaining an early activation phenotype. J Immunol. 2000;164(10):5146-5155.
62. Bingaman AW, Farber DL. Memory T cells in transplantation: generation, function, and potential role in rejection. Am J Transplant. 2004;4(6):846-852. (Pubitemid 38745582)
63. Ibrahim S, Dawson DV, Sanfilippo F. Predominant infiltration of rejecting human renal allografts with T cells expressing CD8 and CD45RO. Transplantation. 1995;59(5):724-728.
64. Colonna-Romano G, Bulati M, Aquino A, et al. B cells in the aged: CD27, CD5, and CD40 expression. Mech Ageing Dev. 2003;124(4):389-393.
65. Nossal GJ, Pike BL. Evidence for the clonal abortion theory of Blymphocyte tolerance. J Exp Med. 1975;141(4):904-917.
66. Cambier JC, Kettman JR, Vitetta ES, Uhr JW. Differential susceptibility of neonatal and adult murine spleen cells to in vitro induction of B-cell tolerance. J Exp Med. 1976;144(1):293-297.
67. Metcalf ES, Klinman NR. In vitro tolerance induction of neonatal murine B cells. J Exp Med. 1976;143(6):1327-1340.
68. Szewczuk MR, Siskind GW. Ontogeny of B-lymphocyte function. III. In vivo and in vitro studies on the ease of tolerance induction in B lymphocytes from fetal, neonatal, and adult mice. J Exp Med. 1977;145(6):1590-1601.
69. LeGuern C. Potential role of major histocompatibility complex class II peptides in regulatory tolerance to vascularized grafts. Transplantation. 2004;77(Suppl 1):S35-S37.
70. LeGuern C. Regulation of T-cell functions by MHC class II self-presentation. Trends Immunol. 2003;24(12):633-638. (Pubitemid 37485912)
71. Benoist C, Mathis D. Regulation ofmajor histocompatibility complex class-II genes: X, Y and other letters of the alphabet. Annu Rev Immunol. 1990;8:681-715.
72. Janick-Buckner D, Briggs CJ, Meyer TE, Harvey N, Warner CM. Major histocompatibility complex antigen expression on lymphocytes from aging strain A mice. Growth Dev Aging. 1991;55(1):53-62.
73. Ginaldi L, De Martinis M, Modesti M, Loreto F, Corsi MP, Quaglino D. Immunophenotypical changes of T lymphocytes in the elderly. Gerontology. 2000;46(5):242-248.
74. Pietschmann P, Hahn P, Kudlacek S, Thomas R, Peterlik M. Surface markers and transendothelial migration of dendritic cells from elderly subjects. Exp Gerontol. 2000;35(2):213-224. (Pubitemid 30190086)
75. Herrero C, Sebastián C, Marqués L, et al. Immunosenescence of macrophages: reduced MHC class II gene expression. Exp Gerontol. 2002;37(2-3):389-394. (Pubitemid 34073556)
76. Dobken J, Weksler ME, Siskind GW. Effect of age on ease of B-cell tolerance induction. Cell Immunol. 1980;55(1):66-73. (Pubitemid 10005797)
77. Nobori S, Shimizu A, Okumi M, et al. Thymic rejuvenation and the induction of tolerance by adult thymic grafts. Proc Natl Acad Sci U S A. 2006;103(50):19081-19086. (Pubitemid 350002831)
78. Zhao L, Sun L, Wang H, Ma H, Liu G, Zhao Y. Changes of CD4+CD25+Foxp3+ regulatory T cells in aged Balb/c mice. J Leukoc Biol. 2007;81(6):1386-1394.
79. Sharma S, Dominguez AL, Lustgarten J. High accumulation of T regulatory cells prevents the activation of immune responses in aged animals. J Immunol. 2006;177(12):8348-8355. (Pubitemid 44893796)
80. Trzonkowski P, Szmit E, Myśliwska J, Myśliwski A. CD4+CD25+ T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans-impact of immunosenescence. Clin Immunol. 2006;119(3):307-316.
81. Hausman PB, Goidl EA, Siskind GW, Weksler ME. Immunological studies of aging. XI. Age-related changes in idiotype repertoire of suppressor T cells stimulated during tolerance induction. J Immunol. 1985;134(6):3802-3807.
82. Tsaknaridis L, Spencer L, Culbertson N, et al. Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity. J Neurosci Res. 2003;74(2):296-308. (Pubitemid 37193716)
83. Kozlowska E, Biernacka M, Ciechomska M, Drela N. Age-related changes in the occurrence and characteristics of thymic CD4(+) CD25(+) T cells in mice. Immunology. 2007;122(3):445-453. (Pubitemid 47556482)
84. Nishioka T, Shimizu J, Iida R, Yamazaki S, Sakaguchi S. CD4+CD25+Foxp3+ T cells and CD4+CD25-Foxp3+ T cells in aged mice. J Immunol. 2006;176(11):6586- 6593.
85. Wood KJ. Passenger leukocytes and microchimerism: what role in tolerance induction? Transplantation. 2003;75(Suppl 9):17S-20S.
86. Effros RB. Costimulatory mechanisms in the elderly. Vaccine. 2000;18(16):1661-1665.
87. Agrawal A, Agrawal S, Tay J, Gupta S. Biology of dendritic cells in aging. J Clin Immunol. 2008;28(1):14-20.
88. Ordemann R, Hutchinson R, Friedman J, et al. Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease. J Clin Invest. 2002;109(9):1249-1256. (Pubitemid 34496603)
89. Castle SC, Uyemura K, Crawford W, Wong W, Makinodan T. Antigen presenting cell function is enhanced in healthy elderly. Mech Ageing Dev. 1999;107(2):137-145. (Pubitemid 29138850)
90. Sidman CL, Luther EA, Marshall JD, Nguyen KA, Roopenian DC, Worthen SM. Increased expression of major histocompatibility complex antigens on lymphocytes from aged mice. Proc Natl Acad Sci U S A. 1987;84(21):7624-7628. (Pubitemid 18035721)
91. Uyemura K, Castle SC, Makinodan T. The frail elderly: role of dendritic cells in the susceptibility of infection. Mech Ageing Dev. 2002;123(8):955-962. (Pubitemid 34603079)
92. Della Bella S, Bierti L, Presicce P, et al. Peripheral blood dendritic cells and monocytes are differently regulated in the elderly. Clin Immunol. 2007;122(2):220-228. (Pubitemid 46073895)
93. Varas A, Sacedón R, Hernandez-López C, et al. Age-dependent changes in thymic macrophages and dendritic cells. Microsc Res Tech. 2003;62(6):501-507. (Pubitemid 37467327)
94. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol. 2003;21:685-711.
95. Leng Q, Bentwich Z, Borkow G. CTLA-4 upregulation during aging. Mech Ageing Dev. 2002;123(10):1419-1421.
96. Azuma M, Phillips JH, Lanier LL. CD28- T lymphocytes. Antigenic and functional properties. J Immunol. 1993;150(4):1147-1159. (Pubitemid 23127405)
97. Lio D, D'Anna C, Gervasi F, et al. Interleukin-12 release by mitogen-stimulated mononuclear cells in the elderly. Mech Ageing Dev. 1998;102(2-3):211-219. (Pubitemid 28353540)
98. Fernández-Gutiérrez B, Jover JA, De Miguel S, et al. Early lymphocyte activation in elderly humans: impaired T and T-dependent B cell responses. Exp Gerontol. 1999;34(2):217-229.
99. Fox A, Harrison LC. Innate immunity and graft rejection. Immunol Rev. 2000;173:141-147.
100. Palmer SM, Burch LH, Davis RD, et al. The role of innate immunity in acute allograft rejection after lung transplantation. Am J Respir Crit Care Med. 2003;168(6):628-632. (Pubitemid 37175964)
101. Obhrai J, Goldstein DR. The role of toll-like receptors in solid organ transplantation. Transplantation. 2006;81(4):497-502. (Pubitemid 43315951)
102. Olszewski WL. Innate immunity processes in organ allografting - their contribution to acute and chronic rejection. Ann Transplant. 2005;10(2):5-9.
103. Gomez CR, Boehmer ED, Kovacs EJ. The aging innate immune system. Curr Opin Immunol. 2005;17(5):457-462.
104. Plackett TP, Boehmer ED, Faunce DE, Kovacs EJ. Aging and innate immune cells. J Leukoc Biol. 2004;76(2):291-299.
105. Plowden J, Renshaw-Hoelscher M, Engleman C, Katz J, Sambhara S. Innate immunity in aging: impact on macrophage function. Aging Cell. 2004;3(4):161-167. (Pubitemid 40246681)
106. Mishto M, Santoro A, Bellavista E, Bonafé M, Monti D, Franceschi C. Immunoproteasomes and immunosenescence. Ageing Res Rev. 2003;2(4):419-432.
107. Fulop T, Larbi A, Douziech N, et al. Signal transduction and functional changes in neutrophils with aging. Aging Cell. 2004;3(4):217-226. (Pubitemid 40246686)
108. Franceschi C, Bonafè M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244-254.
109. Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S. Cutting edge: impaired Toll-like receptor expression and function in aging. J Immunol. 2002;169(9):4697-4701. (Pubitemid 35217128)
110. Boehmer ED, Goral J, Faunce DE, Kovacs EJ. Age-dependent decrease in Toll-like receptor 4-mediated proinflammatory cytokine production and mitogen-activated protein kinase expression. J Leukoc Biol. 2004;75(2):342-349. (Pubitemid 38174592)
111. Chelvarajan RL, Collins SM, Van Willigen JM, Bondada S. The unresponsiveness of aged mice to polysaccharide antigens is a result of a defect in macrophage function. J Leukoc Biol. 2005;77(4):503-512. (Pubitemid 40489526)
112. Park Y, Hirose R, Coatney JL, et al. Ischemia-reperfusion injury is more severe in older versus young rat livers. J Surg Res. 2007;137(1):96-102. (Pubitemid 44879438)
113. Okaya T, Blanchard J, Schuster R, et al. Age-dependent responses to hepatic ischemia/reperfusion injury. Shock. 2005;24(5):421-427. (Pubitemid 41567353)
114. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol. 1994;12:991-1045.
115. Vercelli D. Innate immunity: sensing the environment and regulating the regulators. Curr Opin Allergy Clin Immunol. 2003;3(5):343-346. (Pubitemid 37254713)
116. Gommerman JL, Carroll MC. Negative selection of B lymphocytes: a novel role for innate immunity. Immunol Rev. 2000;173:120-130.
117. Beilke JN, Kuhl NR, Van Kaer L, Gill RG. NK cells promote islet allograft tolerance via a perforin-dependent mechanism. Nat Med. 2005;11(10):1059-1065. (Pubitemid 41486827)
118. De Martinis M, Modesti M, Loreto MF, Quaglino D, Ginaldi L. Adhesion molecules on peripheral blood lymphocyte subpopulations in the elderly. Life Sci. 2000;68(2):139-151.
119. d'Alessio P. Aging and the endothelium. Exp Gerontol. 2004;39(2):165-171.
120. Hoffmann J, Haendeler J, Aicher A, et al. Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ Res. 2001;89(8):709-715. (Pubitemid 34627071)
121. Otterbein LE, Soares MP, Yamashita K, Bach FH. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 2003;24(8):449-455. (Pubitemid 36928103)
122. Ryter SW, Otterbein LE. Carbon monoxide in biology and medicine. Bioessays. 2004;26(3):270-280.
123. Katori M, Busuttil RW, Kupiec-Weglinski JW. Heme oxygenase-1 system in organ transplantation. Transplantation. 2002;74(7):905-912. (Pubitemid 35191234)
124. Verbeke P, Fonager J, Clark BF, Rattan SI. Heat shock response and ageing: mechanisms and applications. Cell Biol Int. 2001;25(9):845-857. (Pubitemid 32783458)
125. Lavrovsky Y, Song CS, Chatterjee B, Roy AK. Age-dependent increase of heme oxygenase-1 gene expression in the liver mediated by NFkappaB. Mech Ageing Dev. 2000;114(1):49-60. (Pubitemid 30154167)
126. Tullius SG, Nieminen-Kelhä M, Buelow R, et al. Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1. Transplantation. 2002;74(5):591-598.
127. Wang XH, Wang K, Zhang F, et al. Alleviating ischemia-reperfusion injury in aged rat liver by induction of heme oxygenase-1. Transplant Proc. 2004;36(10):2917-2923. (Pubitemid 41126706)
128. Oztezcan S, Kirgiz B, Unlüçerçi Y, et al. Heme oxygenase induction protects liver against oxidative stress in x-irradiated aged rats. Biogerontology. 2004;5(2):99-105. (Pubitemid 39139581)
129. Lee YK, Manalo D, Liu AY. Heat shock response, heat shock transcription factor and cell aging. Biol Signals. 1996;5(3):180-191. (Pubitemid 26273311)
130. Surbek DV, Hohlfeld P, Gratwohl A, Holzgreve W. Intrauterine transplantation of hematopoietic stem cells for therapy of genetic diseases [in German]. Z Geburtshilfe Neonatol. 1997;201(5):158-170. (Pubitemid 27471245)
131. Westgren M. In utero stemcell transplantation. Semin Reprod Med. 2006;24(5):348-357.
132. Benito MJ, Lopez-Hoyos M, Fernandez-Fresnedo G, et al. Changes in the expression of the immunoglobulin-like transcript 3 (ILT3) and ILT4 receptors in renal allograft recipients: effect of donor and recipient aging. Transplant Proc. 2008;40(9):2894-2896.
133. Cecka JM. Living donor transplants. Clin Transpl. 1995:363-377.
134. Rianthavorn P, Ettenger RB. Medication non-adherence in the adolescent renal transplant recipient: a clinician's viewpoint. Pediatr Transplant. 2005;9(3):398-407. (Pubitemid 40780374)
135. Fan X, Ang A, Pollock-Barziv SM, et al. Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation. Nat Med. 2004;10(11):1227-1233. (Pubitemid 39540440)
136. Shishido S, Asanuma H, Tajima E, et al. ABO-incompatible living-donor kidney transplantation in children. Transplantation. 2001;72(6):1037-1042. (Pubitemid 32924074)
137. West LJ. B-cell tolerance following ABO-incompatible infant heart transplantation. Transplantation. 2006;81(3):301-307.
138. Squifflet JP, De Meyer M, Malaise J, Latinne D, Pirson Y, Alexandre GP. Lessons learned from ABO-incompatible living donor kidney transplantation: 20 years later. Exp Clin Transplant. 2004;2(1):208-213.
139. Egawa H, Oike F, Buhler L, et al. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation. Transplantation. 2004;77(3):403-411. (Pubitemid 38209740)
140. Roussey-Kesler G, Giral M, Moreau A, et al. Clinical operational tolerance after kidney transplantation. Am J Transplant. 2006;6(4):736-746. (Pubitemid 43345011)
141. Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med. 2008;358(4):353-361. (Pubitemid 351159234)
142. Mazariegos GV, Sindhi R, Thomson AW, Marcos A. Clinical tolerance following liver transplantation: long term results and future prospects. Transpl Immunol. 2007;17(2):114-119. (Pubitemid 46240885)
143. Lerut J, Sanchez-Fueyo A. An appraisal of tolerance in liver transplantation. Am J Transplant 2006; 6 (8): 1774.
144. Alexander SI, Smith N, Hu M, et al. Chimerism and tolerance in a recipient of a deceased-donor liver transplant. N Engl J Med 2008;358(4):369. (Pubitemid 351159236)
145. Fehr T, Sykes M. Clinical experience with mixed chimerism to induce transplantation tolerance. Transpl Int. 2008;21(12):1118-1135.
146. Traum AZ, Kawai T, Vacanti JP, Sachs DH, Cosimi AB, Madsen JC. The need for tolerance in pediatric organ transplantation. Pediatrics. 2008;121(6):1258-1260.
147. Basar H, Soran A, Shapiro R, et al. Renal transplantation in recipients over the age of 60: the impact of donor age. Transplantation. 1999;67(8):1191-1193. (Pubitemid 29205586)
148. Terasaki PI, Gjertson DW, Cecka JM, Takemoto S, Cho YW. Significance of the donor age effect on kidney transplants. Clin Transplant. 1997;11(5 Pt 1):366-372. (Pubitemid 27460429)
149. Mackall CL, Gress RE. Thymic aging and T-cell regeneration. Immunol Rev. 1997;160:91-102.
150. Arlt W, Hewison M. Hormones and immune function: implications of aging. Aging Cell. 2004;3(4):209-216. (Pubitemid 40246685)
151. Taub DD, Longo DL. Insights into thymic aging and regeneration. Immunol Rev. 2005;205:72-93.
152. Polanczyk MJ, Hopke C, Vandenbark AA, Offner H. Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of Treg cells, and enhanced expression of the PD-1 costimulatory pathway. J Neurosci Res. 2006;84(2):370-378. (Pubitemid 44126289)
153. Fülöp T, Larbi A, Hirokawa K, et al. Immunosupportive therapies in aging. Clin Interv Aging. 2007;2(1):33-54.
154. Aspinall R, Andrew D. Thymic involution in aging. J Clin Immunol. 2000;20(4):250-256.
155. Capri M, Monti D, Salvioli S, et al. Complexity of anti-immunosenescence strategies in humans. Artif Organs. 2006;30(10):730-742.
156. Virts EL, Phillips JA, Thoman ML. A novel approach to thymic rejuvenation in the aged. Rejuvenation Res. 2006;9(1):134-142.
157. Savino W, Postel-Vinay MC, Smaniotto S, Dardenne M. The thymus gland: a target organ for growth hormone. Scand J Immunol. 2002;55(5):442-452. (Pubitemid 34451229)
158. De Mello-Coelho V, Savino W, Postel-Vinay MC, Dardenne M. Role of prolactin and growth hormone on thymus physiology. Dev Immunol. 1998;6(3-4):317-323. (Pubitemid 28517788)
159. Dixit VD, Yang H, Sun Y, et al. Ghrelin promotes thymopoiesis during aging. J Clin Invest. 2007;117(10):2778-2790.
160. Bruinsma M, van Soest PL, Leenen PJ, et al. Keratinocyte growth factor induces expansion of murine peripheral CD4+Foxp3+ regulatory T cells and increases their thymic output. J Immunol. 2007;179(11):7424-7430.
161. Sportès C, Gress RE. Interleukin-7 immunotherapy. Adv Exp Med Biol. 2007;601:321-333.
162. Henson SM, Pido-Lopez J, Aspinall R. Reversal of thymic atrophy. Exp Gerontol. 2004;39(4):673-678.
163. Wils EJ, Cornelissen JJ. Thymopoiesis following allogeneic stem cell transplantation: new possibilities for improvement. Blood Rev. 2005;19(2):89-98. (Pubitemid 39643114)
164. Haq AU. 1,25-Dihydroxyvitamin D3 (calcitriol) suppresses IL-2 induced murine thymocyte proliferation. Thymus. 1986;8(5):295-306.
165. Vallabhajosyula P, Griesemer A, Yamada K, Sachs DH. Vascularized composite islet-kidney transplantation in a miniature swine model. Cell Biochem Biophys. 2007;48(2-3):201-207. (Pubitemid 47340887)
166. Martins PN, Chandraker A, Tullius SG. Modifying graft immunogenicity and immune response prior to transplantation: potential clinical applications of donor and graft treatment. Transpl Int. 2006;19(5):351-359.
167. Reutzel-Selke A, Zschockelt T, Denecke C, et al. Short-term immunosuppressive treatment of the donor ameliorates consequences of ischemia/ reperfusion injury and long-term graft function in renal allografts from older donors. Transplantation. 2003;75(11):1786-1792. (Pubitemid 36734632)
168. Bluestone JA. Regulatory T-cell therapy: is it ready for the clinic? Nat Rev Immunol. 2005;5(4):343-349.
169. Bluestone JA, Thomson AW, Shevach EM, Weiner HL. What does the future hold for cell-based tolerogenic therapy? Nat Rev Immunol. 2007;7(8):650-654.
170. Salama AD, Womer KL, Sayegh MH. Clinical transplantation tolerance: many rivers to cross. J Immunol. 2007;178(9):5419-5423. (Pubitemid 46674334)
171. Monaco AP. The beginning of clinical tolerance in solid organ allografts. Exp Clin Transplant. 2004; 2(1):153-161.
172. Monaco AP. Strategies for induction of clinical tolerance. Transplant Proc. 2001;33: 51-56.
173. Fehr T, Sykes M. Tolerance induction in clinical transplantation. Transpl Immunol. 2004;13:117-130.
174. Kirk AD. Clinical tolerance 2008. Transplantation. 2009;87(7):953-955.
175. Seach N, Layton D, Lim J, Chidgey A, Boyd R. Thymic generation and regeneration: a new paradigm for establishing clinical tolerance of stem cell-based therapies. Curr Opin Biotechnol. 2007;18(5):441-447. (Pubitemid 350119857)